We have previously shown that DHA inhibits mTOR activity in trophoblast cells, which may indicate that DHA supplementation is a mechanism for reducing mTOR activity in the placentas of pregnancies complicated by obesity by lowering activating phospholipids. The gene discussed is MTOR; the disease is obesity due to melanocortin 4 receptor deficiency.